Benefits of ACP-105?

What exactly is the ACP-105?

Acadia’s novel selective androgen receptor modulator (SARM), known as ACP-105, targets androgen receptors in the body. According to the product manufacturer, in in-vitro tests, the anabolic impact of ACP-105 is just as powerful as that of testosterone. As a result of its strong affinity for skeletal muscle, which was established in pre-clinical testing, ACP-105 is classified as a real SARM.

When compared with other SARMs such as Ostarine, the amount of clinical evidence available on ACP-105 is quite limited. This is also the case with RAD 150, another novel SARM that we spoke about not too long ago. However, what there is to look forward to is clearly encouraging.

A brief explanation of what selective androgen receptor modulators (SARMs) are and how they should be utilised will follow this introduction to the topic of ACP-105. If you are interested in learning more about SARMs, we suggest that you have a look at our comprehensive introduction to the topic, which is a part of our Ultimate Series on SARMs.

Our reliable supplier  has stock of ACP-105 in their inventory. By using the code “HS11,” you will receive a discount of 11 percent on any SARM that is sold on their website.

Just what are these SARMs? What Do You Do With Them?

The term “selective androgen receptor modulators” is abbreviated as “SARMS.” These substances function in a manner that is analogous to that of steroids; they link to the androgen (male hormone) receptors in the body and recode DNA in order to make the body more “tissue selective” in its ability to pack on muscle mass.

Individual SARMs, in contrast to anabolic steroids, typically bind to estrogen receptor in numerous tissues throughout the body, specifically bind to endogenous testosterone in just the tissues in which they are present, while remaining unbound in other tissues.

These SARMs were initially developed as “steroidal SARMS” for a feasible therapy for osteoporosis, cancer, and other diseases. At that time, looking for a cure for osteoporosis, cancer, and other diseases.

In recent years, selective androgen receptor modulators (SARMs) have presented themselves as an appealing alternative to androgenic anabolic steroids (AAS). This is due to the fact that SARMs boast less adverse effects and that they inhabit a legal grey area. With a few noteworthy exceptions, where they must be obtained with a doctor’s prescription, SARMs are considered to be legal in most jurisdictions.

It is important to note, however, that the majority of SARMs are considered illegal substances because of their anabolic and performance-enhancing effects. This is because they are designated as an S1 Anabolic Agent on the restricted list maintained by WADA.

Because SARMs are more “skin” while gloating far as there are less androgenic side effects, such as hair loss, acne, become more, clitoral enlargement, unsolicited hair, etc., they have begun to become more popular than AAS in many parts of the world. This trend is expected to continue in the foreseeable future.

SARMs are used by bodybuilders and powerlifters equally, and sometimes both types of athletes combine SARMs and steroid use to achieve their goals. This is due to the fact that SARMs can result in improvements in muscle and strength that can be maintained without causing significant hormonal alterations.

If you don’t like the notion of injecting yourself with an anabolic chemical, you won’t have to worry about that with SARMs because they are often eaten in liquid form. This is another plus.

Cycles of SARMs normally last between two and three months, depending on the chemical or stack (a mixture of compounds taken), however this can vary based on a number of factors including the stack, user experience, and dose.

Just how Powerful is the ACP 105?

Some website reviewed the limited research available on ACP-105, which includes the two studies shown here (one and two), and has the following to say about the substance.

“It was established that the percent of anabolic function was 67 percent, with just 21 percent reversing of the seminal vesicles” (which is used to measure androgenic activity).

As a result of this, we are able to draw the conclusion that this SARM possesses an anabolic:androgenic rating or ratio of 3.19:1.

However, there are a few SARMs which have muscle protein synthesis ratios of 3:1 or more, thus this may be considered to be quite common.

Although we have a general idea of what to anticipate from this molecule (Ostarine and S4 are two analogies that come to mind), because we do not know the binding affinity of the compound, our predictions are, at best, wild guesses.

However, we are aware of the type of interaction that ACP-105 has with the androgen receptor, which enables us to understand the situation a little bit better.

We know that ACP-105 is a partial agonist because we analysed all of the material that was accessible to us.

Full agonists are associated with higher levels of suppression, but they have a bigger impact (based on the information presented).

On the other side, partial agonists have a lower suppressive effect, but in comparison to testosterone and DHT, they are often weaker. ACP-105 is an example of such a compound.

The androgen receptor can be attached to by a relatively low concentration of ACP-105 better than it can be attached to by DHT, although ACP-105 is obviously weaker than Testosterone and DHT in general.

In one sense, this is a letdown because we are all anticipating the launch of the ultimate SARM—one that exerts only a moderate amount of suppression, has androgenic side effects that are either minimal or nonexistent, and can compete with or outperform testosterone in terms of its overall anabolic activity.

It would be more beneficial to just compare ACP-105 to the other most promising mainstream SARMs to assess if it has a place in a researcher’s up and coming test protocols rather than making such a lofty request, which is already asking a lot.

In terms of its anabolic effects, it appears that ACP-105 is about comparable to both Ostarine and Andarine.

A second study, experimentation on mice, some of which had been administered ACP-105 and some of which had not, to radiation and the results were compared, also appears to suggest that govt of the Supplement may have benefits for motor skills such as increased speed, endurance, balance, and coordination. The mice in this study were exposed to radiation.


Due to the fact that ACP 105 is still relatively new, there is not a significant quantity of information that is currently available.

According to the research that have been conducted on ACP 105, the recommended human dose is around 11 mg per day. Even though there isn’t a great deal of information accessible, most people tend to think that a dose of 10-15 mg per day is appropriate.

It is important to note that ACP-105, like Stenabolic, has a short half-life. Because of this, it is possible that you may need to give it up to three times per day, as the commenter below from Reddit explains. Because of this, it is possible that some people will find it more convenient to use a SARM like Ostarine that has a longer half-life.

Should I Perform a PCT Before Taking ACP-105?

However, the individual reaction will vary, and certain compounds, such as Ostarine, are typically thought to be less “suppressive” than others. This is because SARMs replicate the role of naturally generated androgens in the human body, which causes them to lower levels of estrogen. As a consequence of this, some cycles of SARMs may call for post-cycle treatment (PCT) quickly after consumption, or even liver protection such as NAC, in order to prevent the hepatotoxicity that might follow from taking specific oral chemicals.

It is abundantly obvious that ACP-105 is just a partial rather than a complete agonist, which indicates that it will have a hormone-suppressing action that is far less potent than that of a SARM such as LGD-4033. We are of the opinion that it is probably advisable for you to operate with the assumption that you will require some kind of PCT. In an ideal scenario, you would have blood work done before the beginning of your cycle, throughout it, and after it. This would allow you to properly evaluate the degree to which the SARM has or has not reduced the levels of your natural hormones.

Buy ACP-105 in UK today

Select your currency
GBP Pound sterling
EUR Euro